Personalized medicine in the era of genomics.
paper
Cited
Public
Unavailable
- Authors
- Burke, Wylie; Psaty, Bruce M
- Year
- 2007
- Journal
- JAMA
- PMID
- 17925520
- DOI
- 10.1001/jama.298.14.1682
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Commentary for Special Issue of Prevention Science "Using Genetics in Prevention: Science Fiction or Science Fact?". | 2018 | 28735446 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Barriers, facilitators, and implementation strategies for pharmacogenomics in community pharmacies: a cross-sectional survey among local champions in pharmacies and key opinion leaders in pharmacogenomics. | Kiani P et al. | — | 2026 | → |
| Benchmarking Alzheimer's disease prediction: personalised risk assessment using polygenic risk scores across various methodologies and genome-wide studies. | Bellou E et al. | — | 2025 | → |
| Developing the MyCancerGene Digital Health Portal to Improve Patients' Understanding of Germline Cancer Genetic Test Results: Development, User, and Usability Testing Study. | Trieu P et al. | — | 2025 | → |
| Exploring the Potential of Precision Medicine in Neuropsychiatry: A Commentary on New Insights for Tailored Treatments Based on Genetic, Environmental, and Lifestyle Factors. | Milic J et al. | — | 2025 | → |
| Preconcentration and purification of oligonucleotides from heat-treated human plasma by anion-exchange microextraction devices coupled to high performance liquid chromatography-mass spectrometry. | Eitzmann DR et al. | — | 2025 | → |
| Facile Preconcentration of Cell-Free DNA in Human Plasma by Ion-Specific Poly Ionic Sorbents Featuring an Anion Exchange Mechanism. | Eitzmann DR et al. | — | 2024 | → |
| Back to the Basics: Usefulness of Naturally Aged Mouse Models and Immunohistochemical and Quantitative Morphologic Methods in Studying Mechanisms of Lung Aging and Associated Diseases. | Jaramillo-Rangel G et al. | — | 2023 | → |
| Multiomics Approach to Acromegaly: Unveiling Translational Insights for Precision Medicine. | Kim K et al. | — | 2023 | → |
| The Microbiome of Osteoarthritic Hip and Knee Joints: A Prospective Multicenter Investigation. | Goswami K et al. | — | 2023 | → |
| Diabetes and Heart Failure: Multi-Omics Approaches. | Tayanloo-Beik A et al. | — | 2021 | → |
| Utility and Diversity: Challenges for Genomic Medicine. | Burke W | — | 2021 | → |
| Health Economics Tools and Precision Medicine: Opportunities and Challenges. | Veenstra DL et al. | — | 2020 | → |
| Personalized medicine, digital technology and trust: a Kantian account. | Myskja BK et al. | — | 2020 | → |
| A clinical trial design with covariate-adjusted response-adaptive randomization using superiority confidence of treatments. | Qiao W et al. | — | 2019 | → |
| Cancer communication research in the era of genomics and precision medicine: a scoping review. | Kaphingst KA et al. | — | 2019 | → |
| Design of training populations for selective phenotyping in genomic prediction. | Akdemir D et al. | — | 2019 | → |
| Moving Toward a Precision-Based, Personalized Framework for Prevention Science: Introduction to the Special Issue. | August GJ et al. | — | 2019 | → |
| Precision medicine in colorectal cancer. | Aziz MA | — | 2019 | → |
| Precision Medicine vs Preventive Medicine-Reply. | Psaty BM et al. | — | 2019 | → |
| Research participants' experiences with return of genetic research results and preferences for web-based alternatives. | Gaieski JB et al. | — | 2019 | → |
| SAFETY: Secure gwAs in Federated Environment through a hYbrid Solution. | Sadat MN et al. | — | 2019 | → |
| BRCA Mutations in the Young, High-Risk Female Population: Genetic Testing, Management of Prophylactic Therapies, and Implications for Plastic Surgeons. | Salibian AA et al. | — | 2018 | → |
| Characterization of epithelial oral dysplasia in non-smokers: First steps towards precision medicine. | Rock LD et al. | — | 2018 | → |
| Commentary for Special Issue of Prevention Science "Using Genetics in Prevention: Science Fiction or Science Fact?" | Dick DM | — | 2018 | → |
| Attitude toward Prenatal Testing and Termination of Pregnancy among Health Professionals and Medical Students in Saudi Arabia. | A Gaboon NE et al. | — | 2017 | → |
| Nanomedicine and personalised medicine: understanding the personalisation of health care in the molecular era. | Noury M et al. | — | 2017 | → |
| Acetaminophen Induced Hepatotoxicity in Wistar Rats--A Proteomic Approach. | Ilavenil S et al. | — | 2016 | → |
| A Framework for Prioritizing Research Investments in Precision Medicine. | Basu A et al. | — | 2016 | → |
| Comparative Effectiveness of Personalized Lifestyle Management Strategies for Cardiovascular Disease Risk Reduction. | Chu P et al. | — | 2016 | → |
| Conceptual and terminological confusion around personalised medicine: a coping strategy. | De Grandis G et al. | — | 2016 | → |
| Epidemiology: Then and Now. | Kuller LH | — | 2016 | → |
| Exposure to Pre- and Perinatal Risk Factors Partially Explains Mean Differences in Self-Regulation between Races. | Barnes JC et al. | — | 2016 | → |
| The Significance of an Enhanced Concept of the Organism for Medicine. | Rosslenbroich B | — | 2016 | → |
| BOOGIE: Predicting Blood Groups from High Throughput Sequencing Data. | Giollo M et al. | — | 2015 | → |
| Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management. | Slavin TP et al. | — | 2015 | → |
| Closing the gap between knowledge and clinical application: challenges for genomic translation. | Burke W et al. | — | 2015 | → |
| Communicating results in post-Belmont era biomonitoring studies: lessons from genetics and neuroimaging research. | Morello-Frosch R et al. | — | 2015 | → |
| The Human Genome Project, and recent advances in personalized genomics. | Wilson BJ et al. | — | 2015 | → |
| Translating personalized genomic medicine into clinical practice: evidence, values, and health policy. | Bombard Y | — | 2015 | → |
| Unwarranted optimism in media portrayals of genetic research on addiction overshadows critical ethical and social concerns. | Ostergren JE et al. | — | 2015 | → |
| An ontology-based, mobile-optimized system for pharmacogenomic decision support at the point-of-care. | Miñarro-Giménez JA et al. | — | 2014 | → |
| Biobanks and personalized medicine. | Olson JE et al. | — | 2014 | → |
| Development of a communication protocol for telephone disclosure of genetic test results for cancer predisposition. | Patrick-Miller LJ et al. | — | 2014 | → |
| Genes, the environment and personalized medicine: We need to harness both environmental and genetic data to maximize personal and population health. | Carlsten C et al. | — | 2014 | → |
| Genetic tests: clinical validity and clinical utility. | Burke W | — | 2014 | → |
| Legal aspects of biobanking as key issues for personalized medicine and translational exploitation. | Minssen T et al. | — | 2014 | → |
| Mass spectrometry-based proteomics in Chest Medicine, Gerontology, and Nephrology: subgroups omics for personalized medicine. | Lin SY et al. | — | 2014 | → |
| Pediatric data sharing in genomic research: attitudes and preferences of parents. | Burstein MD et al. | — | 2014 | → |
| Personalized medicine, availability, and group disparity: an inquiry into how physicians perceive and rate the elements and barriers of personalized medicine. | Petersen KE et al. | — | 2014 | → |
| 'Personalized medicine': what's in a name? | Pokorska-Bocci A et al. | — | 2014 | → |
| Anticipating the arrival of low-penetrance genetic testing to primary care medicine. | Tarini BA et al. | — | 2013 | → |
| Barriers for integrating personalized medicine into clinical practice: a qualitative analysis. | Najafzadeh M et al. | — | 2013 | → |
| Ethical and practical challenges to studying patients who opt out of large-scale biorepository research. | Rosenbloom ST et al. | — | 2013 | → |
| Impact of the environment on the skeleton: is it modulated by genetic factors? | Ackert-Bicknell CL et al. | — | 2013 | → |
| Implementation and outcomes of telephone disclosure of clinical BRCA1/2 test results. | Patrick-Miller L et al. | — | 2013 | → |
| "Is it really worth it to get tested?": primary care patients' impressions of predictive SNP testing for colon cancer. | Leventhal KG et al. | — | 2013 | → |
| Mapping the incidentalome: estimating incidental findings generated through clinical pharmacogenomics testing. | Westbrook MJ et al. | — | 2013 | → |
| Medicine. (De)personalized medicine. | Horwitz RI et al. | — | 2013 | → |
| Meta-analysis investigating associations between healthy diet and fasting glucose and insulin levels and modification by loci associated with glucose homeostasis in data from 15 cohorts. | Nettleton JA et al. | — | 2013 | → |
| Personalised medicine: a critique on the future of health care. | Savard J | — | 2013 | → |
| Physio-environmental sensing and live modeling. | Castiglione F et al. | — | 2013 | → |
| The benefits of using genetic information to design prevention trials. | Hu Y et al. | — | 2013 | → |
| After the revolution? Ethical and social challenges in 'personalized genomic medicine' | Juengst ET et al. | — | 2012 | → |
| An Altered Treatment Plan Based on Direct to Consumer (DTC) Genetic Testing: Personalized Medicine from the Patient/Pin-cushion Perspective. | Tenenbaum JD et al. | — | 2012 | → |
| Barriers to integrating personalized medicine into clinical practice: a best-worst scaling choice experiment. | Najafzadeh M et al. | — | 2012 | → |
| Genetic characteristics of Sasang typology: a systematic review. | Sohn K et al. | — | 2012 | → |
| Genetic counseling and the ethical issues around direct to consumer genetic testing. | Hawkins AK et al. | — | 2012 | → |
| Knowledge and perceptions of familial and genetic risks for breast cancer risk in adolescent girls. | Bradbury AR et al. | — | 2012 | → |
| Motivations and perceptions of early adopters of personalized genomics: perspectives from research participants. | Gollust SE et al. | — | 2012 | → |
| Patient-controlled encrypted genomic data: an approach to advance clinical genomics. | Trakadis YJ | — | 2012 | → |
| When parents disclose BRCA1/2 test results: their communication and perceptions of offspring response. | Bradbury AR et al. | — | 2012 | → |
| Why personalized medicine will fail if we stay the course. | Ramos E et al. | — | 2012 | → |
| Design of a randomized trial of diabetes genetic risk testing to motivate behavior change: the Genetic Counseling/lifestyle Change (GC/LC) Study for Diabetes Prevention. | Grant RW et al. | — | 2011 | → |
| Electronic medical records for genetic research: results of the eMERGE consortium. | Kho AN et al. | — | 2011 | → |
| Genetic counselor opinions of, and experiences with telephone communication of BRCA1/2 test results. | Bradbury AR et al. | — | 2011 | → |
| Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine. | Weitzel JN et al. | — | 2011 | → |
| GenetiKit: a randomized controlled trial to enhance delivery of genetics services by family physicians. | Carroll JC et al. | — | 2011 | → |
| Genomic risk profiling: attitudes and use in personal and clinical care of primary care physicians who offer risk profiling. | Haga SB et al. | — | 2011 | → |
| Identifiability in biobanks: models, measures, and mitigation strategies. | Malin B et al. | — | 2011 | → |
| Improving health care outcomes through personalized comparisons of treatment effectiveness based on electronic health records. | Hoffman S et al. | — | 2011 | → |
| Looking to the future of research in pediatric anxiety disorders. | March JS | — | 2011 | → |
| Pharmacogenetics of smoking cessation in general practice: results from the patch II and patch in practice trials. | David SP et al. | — | 2011 | → |
| Reconsidering the criteria for evaluating proposed screening programs: reflections from 4 current and former members of the U.S. Preventive services task force. | Harris R et al. | — | 2011 | → |
| Using Alzheimer's disease as a model for genetic risk disclosure: implications for personal genomics. | Roberts JS et al. | — | 2011 | → |
| A formal risk-benefit framework for genomic tests: facilitating the appropriate translation of genomics into clinical practice. | Veenstra DL et al. | — | 2010 | → |
| Bioethics and the reinforcement of socio-technical expectations. | Hedgecoe A | — | 2010 | → |
| Considerations for designing a prototype genetic test for use in translational research. | Wade CH et al. | — | 2010 | → |
| Cumulative association of 22 genetic variants with seropositive rheumatoid arthritis risk. | Karlson EW et al. | — | 2010 | → |
| Debating clinical utility. | Burke W et al. | — | 2010 | → |
| Extending comprehensive cancer center expertise in clinical cancer genetics and genomics to diverse communities: the power of partnership. | MacDonald DJ et al. | — | 2010 | → |
| Findings from a community education needs assessment to facilitate the integration of genomic medicine into primary care. | Christianson CA et al. | — | 2010 | → |
| Human difference in the genomic era: Facilitating a socially responsible dialogue. | Knerr S et al. | — | 2010 | → |
| Interactions of dietary whole-grain intake with fasting glucose- and insulin-related genetic loci in individuals of European descent: a meta-analysis of 14 cohort studies. | Nettleton JA et al. | — | 2010 | → |
| Interobserver diagnostic variability at "moderate" agreement levels could significantly change the prognostic estimates of clinicopathologic studies: evaluation of the problem using evidence from patients with diffuse lung disease. | Marchevsky AM et al. | — | 2010 | → |
| Loss-of-function CYP2C9 variants: finding the correct clinical role for Type 2 diabetes pharmacogenetic testing. | Grant RW et al. | — | 2010 | → |
| Personalized medicine for depression: can we match patients with treatments? | Simon GE et al. | — | 2010 | → |
| Rapid-learning system for cancer care. | Abernethy AP et al. | — | 2010 | → |
| Targeted Therapy Database (TTD): a model to match patient's molecular profile with current knowledge on cancer biology. | Mocellin S et al. | — | 2010 | → |
| The prospect of genome-guided preventive medicine: a need and opportunity for genetic counselors. | O'Daniel JM | — | 2010 | → |
| The use of personalized medicine for patient selection for renal transplantation: physicians' views on the clinical and ethical implications. | Dion-Labrie M et al. | — | 2010 | → |
| Age-neutral guidelines for the primary prevention of cardiovascular disease. | Kostis WJ et al. | — | 2009 | → |
| A national clinical decision support infrastructure to enable the widespread and consistent practice of genomic and personalized medicine. | Kawamoto K et al. | — | 2009 | → |
| Application of pharmacogenomics to vaccines. | Poland GA et al. | — | 2009 | → |
| Careers in cardiovascular outcomes research. | Kosiborod M et al. | — | 2009 | → |
| Comparisons of prevention programs for homeless youth. | Arnold EM et al. | — | 2009 | → |
| Disclosure of APOE genotype for risk of Alzheimer's disease. | Green RC et al. | — | 2009 | → |
| Does genomic risk information motivate people to change their behavior? | Henrikson NB et al. | — | 2009 | → |
| Forging a critical alliance: Addressing the research needs of the United States critical illness and injury community. | Cobb JP et al. | — | 2009 | → |
| From genetics to genomics: ethics, policy, and parental decision-making. | Wilfond B et al. | — | 2009 | → |
| Genetic architecture of type 2 diabetes: recent progress and clinical implications. | Grant RW et al. | — | 2009 | → |
| Opportunities for the cost reduction of medical care. | Malach M et al. | — | 2009 | → |
| Physicians' attitudes toward race, genetics, and clinical medicine. | Bonham VL et al. | — | 2009 | → |
| Public awareness and use of direct-to-consumer genetic tests: results from 3 state population-based surveys, 2006. | Goddard KA et al. | — | 2009 | → |
| Social networkers' attitudes toward direct-to-consumer personal genome testing. | McGuire AL et al. | — | 2009 | → |
| The clinical application of genetic testing in type 2 diabetes: a patient and physician survey. | Grant RW et al. | — | 2009 | → |
| The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group. | Teutsch SM et al. | — | 2009 | → |
| Tissue-level modeling of xenobiotic metabolism in liver: An emerging tool for enabling clinical translational research. | Lerapetritou MG et al. | — | 2009 | → |
| Translating genomics into the clinic: moving to the post-Mendelian world. | Cho MK | — | 2009 | → |
| Use of Factor V Leiden genetic testing in practice and impact on management. | Laberge AM et al. | — | 2009 | → |
| Use of personalized medicine in the selection of patients for renal transplantation: views of Quebec transplant physicians and referring nephrologists. | Dion-Labrie M et al. | — | 2009 | → |
| Using lifetime risk estimates in personal genomic profiles: estimation of uncertainty. | Yang Q et al. | — | 2009 | → |
| ASHG Presidential Address: Who is under the umbrella--and why are we here? | Burke W | — | 2008 | → |
| Development of a large-scale de-identified DNA biobank to enable personalized medicine. | Roden DM et al. | — | 2008 | → |
| Linking molecular classification of hepatocellular carcinoma and personalized medicine: preliminary steps. | Villanueva A et al. | — | 2008 | → |
| Personalized screening for colorectal cancer. | Fletcher RH | — | 2008 | → |
| Perspective on the future use of genomics in exercise prescription. | Roth SM | — | 2008 | → |
| Research ethics and the challenge of whole-genome sequencing. | McGuire AL et al. | — | 2008 | → |
| The changing scenario in laboratory medicine and the role of laboratory professionals in translational medicine. | Plebani M | — | 2008 | → |
| The rise and impending decline of screening mammography. | Hall FM | — | 2008 | → |
| Why should genomic medicine become more evidence-based? | Khoury MJ et al. | — | 2007 | → |